<?xml version="1.0" encoding="UTF-8"?><feed xmlns="http://www.w3.org/2005/Atom">
  <title>药融圈 | wechat-feeds</title>
  <id>https://github.com/hellodword/wechat-feeds</id>
  <updated>2021-01-19T12:17:21+08:00</updated>
  <subtitle>药融圈PHARNEX汇聚数万医药大咖，得到数千家医药创业者鼎力支持，开展日常专题讲座。致力于成为“专业、前沿、权威、严谨”的医药行业资讯平台，以及项目、技术、工厂、融资、股权投资等资源整合平台。欢迎您关注药融圈，共同碰撞“药”的火花!</subtitle>
  <link href="https://github.com/hellodword/wechat-feeds"></link>
  <author>
    <name>hellodword</name>
  </author>
  <entry>
    <title>2021预测：这些医药企业或将登陆科创板</title>
    <updated>2021-01-18T16:48:55+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-18:/s/VqcVy_iNLOrsLZ-ied07tA</id>
    <link href="https://mp.weixin.qq.com/s/VqcVy_iNLOrsLZ-ied07tA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>国内Biotech Top:近1200亿再鼎医药的内部研发管线</title>
    <updated>2021-01-18T16:48:55+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-18:/s/zOHlfxGILO3tP59C7wd38g</id>
    <link href="https://mp.weixin.qq.com/s/zOHlfxGILO3tP59C7wd38g" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>常山药业：完善肝素产业链，新药研发积极推进</title>
    <updated>2021-01-18T16:48:55+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-18:/s/s8VeGd330CooXeD-wQu3UQ</id>
    <link href="https://mp.weixin.qq.com/s/s8VeGd330CooXeD-wQu3UQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>齐鲁制药第51个品种过评，注射用头孢曲松钠</title>
    <updated>2021-01-18T16:48:55+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-18:/s/kdZwPMd6LrRZPsrtAuj0Uw</id>
    <link href="https://mp.weixin.qq.com/s/kdZwPMd6LrRZPsrtAuj0Uw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>CDE发布《抗肿瘤药临床试验影像评估程序标准技术指导原则》</title>
    <updated>2021-01-18T16:48:55+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-18:/s/NkVScOQGYkJ2Zf48NGiqCw</id>
    <link href="https://mp.weixin.qq.com/s/NkVScOQGYkJ2Zf48NGiqCw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>开发遗传性血管性水肿新药，Pharvaris提交IPO申请拟募资1亿美元！</title>
    <updated>2021-01-18T16:48:55+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-18:/s/JrliT0G_sDex6WzWxmJ0KA</id>
    <link href="https://mp.weixin.qq.com/s/JrliT0G_sDex6WzWxmJ0KA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>海思科自主研发麻醉药HSK-3486美国III期临床试验获FDA同意</title>
    <updated>2021-01-18T16:48:55+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-18:/s/GaYrtU0lRWqWXvuuvKNQHg</id>
    <link href="https://mp.weixin.qq.com/s/GaYrtU0lRWqWXvuuvKNQHg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>来自斯坦福大学，免疫刺激抗体偶联平台提交IPO拟募资1亿美元！</title>
    <updated>2021-01-18T16:48:55+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-18:/s/6iLPBTngWwq3zguItuH0Iw</id>
    <link href="https://mp.weixin.qq.com/s/6iLPBTngWwq3zguItuH0Iw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>心血管重磅新药VASCEPA®落地博鳌，专家解读心血管事件残余风险破解之法</title>
    <updated>2021-01-17T22:18:11+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-17:/s/tbq-vwYvzpKQ74VQOIyVwQ</id>
    <link href="https://mp.weixin.qq.com/s/tbq-vwYvzpKQ74VQOIyVwQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>百明信康完成近2亿元A轮融资，打造领先过敏诊疗平台</title>
    <updated>2021-01-17T22:18:11+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-17:/s/zVpNfhtIKrRQgtN4r_vn8g</id>
    <link href="https://mp.weixin.qq.com/s/zVpNfhtIKrRQgtN4r_vn8g" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>“长寿药”NMN迎来致命打击 ，国家局启动严查</title>
    <updated>2021-01-17T22:18:11+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-17:/s/ADdJz7magQhR5Y7zUKvr7w</id>
    <link href="https://mp.weixin.qq.com/s/ADdJz7magQhR5Y7zUKvr7w" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>新锐|A轮融资6200万美元，加速taladegib治疗特发性肺纤维化临床</title>
    <updated>2021-01-17T22:18:11+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-17:/s/N9geameuwosi7YJbLDYlrA</id>
    <link href="https://mp.weixin.qq.com/s/N9geameuwosi7YJbLDYlrA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>B轮超额融资6200万美元，仅有一款MEK抑制剂处于临床前</title>
    <updated>2021-01-17T22:18:11+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-17:/s/-zZyt6-APiwpB2O0eTYenw</id>
    <link href="https://mp.weixin.qq.com/s/-zZyt6-APiwpB2O0eTYenw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>靶点药讯44|纵览全球药物靶点动态</title>
    <updated>2021-01-17T22:18:11+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-17:/s/tnz28VhCV5-PXFL_m38Ptw</id>
    <link href="https://mp.weixin.qq.com/s/tnz28VhCV5-PXFL_m38Ptw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>结束20余年备胎生涯---诺华奥马珠单抗重磅接班人Ligelizumab现身台前</title>
    <updated>2021-01-17T22:18:11+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-17:/s/3yw0BbPIxVzTfyYroJhzeQ</id>
    <link href="https://mp.weixin.qq.com/s/3yw0BbPIxVzTfyYroJhzeQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>不内卷||细数那些转型CMO/CDMO成功的原料药企</title>
    <updated>2021-01-16T20:38:03+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-16:/s/-cfps01tP3s_bJg0LZMafQ</id>
    <link href="https://mp.weixin.qq.com/s/-cfps01tP3s_bJg0LZMafQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>重磅！大数据智能医疗公司医渡云港股正式IPO，市值达574亿港元</title>
    <updated>2021-01-16T20:38:03+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-16:/s/eMWOxa1QzGMHDh2w9qIf5Q</id>
    <link href="https://mp.weixin.qq.com/s/eMWOxa1QzGMHDh2w9qIf5Q" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>1100万美元A轮融资，加快治疗淋巴水肿和静脉疾病产品商业化</title>
    <updated>2021-01-16T20:38:03+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-16:/s/9y6JBmNCJQ-RB2PVd6PCpw</id>
    <link href="https://mp.weixin.qq.com/s/9y6JBmNCJQ-RB2PVd6PCpw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>B轮融资1.55亿美元，加速IDO和PD-L1癌症疫苗临床试验</title>
    <updated>2021-01-16T20:38:03+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-16:/s/k34_yXmXtpExcmH9RXGXbw</id>
    <link href="https://mp.weixin.qq.com/s/k34_yXmXtpExcmH9RXGXbw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>纳入十四五规划，疫苗行业千亿市场规模近在咫尺</title>
    <updated>2021-01-16T20:38:03+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-16:/s/5f98r36xjXrg4KW8c4Rcfw</id>
    <link href="https://mp.weixin.qq.com/s/5f98r36xjXrg4KW8c4Rcfw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
</feed>